| scholarly article | Q13442814 |
| P50 | author | Mika Kivimäki | Q37386335 |
| Kristine Færch | Q40787175 | ||
| Daniel R. Witte | Q40787260 | ||
| Dorte Vistisen | Q42599747 | ||
| Adam G Tabak | Q57353570 | ||
| Eric J Brunner | Q58438211 | ||
| Leigh Perreault | Q116782368 | ||
| P2093 | author name string | Christian Herder | |
| P2860 | cites work | Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 |
| International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes | Q24642456 | ||
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 | ||
| General cardiovascular risk profile for use in primary care: the Framingham Heart Study | Q29614189 | ||
| Declining β-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth. | Q35179833 | ||
| Associations of common genetic variants with age-related changes in fasting and postload glucose: evidence from 18 years of follow-up of the Whitehall II cohort | Q35797059 | ||
| Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: the KORA F4 study | Q36181303 | ||
| Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study. | Q36426822 | ||
| Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes? | Q36846154 | ||
| Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study | Q37105194 | ||
| Progression to impaired glucose regulation and diabetes in the population-based Inter99 study | Q37139545 | ||
| Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
| Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. | Q37304741 | ||
| Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial | Q38486659 | ||
| Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study | Q43150604 | ||
| Differential relationship between physical activity and progression to diabetes by glucose tolerance status: the Inter99 Study | Q43245998 | ||
| Ethnic comparison of the association of undiagnosed diabetes with obesity | Q43249943 | ||
| Disturbances in beta-cell function in impaired fasting glycemia. | Q43869387 | ||
| The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging | Q44453020 | ||
| Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging | Q44995554 | ||
| Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? | Q45933172 | ||
| Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. | Q51474202 | ||
| Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. | Q51484657 | ||
| Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. | Q51551674 | ||
| Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. | Q51557396 | ||
| Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. | Q51560180 | ||
| Cohort Profile: The Whitehall II study | Q57241528 | ||
| Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe | Q77924493 | ||
| P433 | issue | 1 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 43-51 | |
| P577 | publication date | 2013-02-21 | |
| P1433 | published in | The Lancet: Diabetes & Endocrinology | Q27725107 |
| P1476 | title | Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study | |
| P478 | volume | 1 |
| Q54440700 | A statistical model to describe longitudinal and correlated metabolic risk factors: the Whitehall II prospective study. |
| Q33771885 | Bayesian hierarchical piecewise regression models: a tool to detect trajectory divergence between groups in long-term observational studies |
| Q37684091 | Body mass index trajectory patterns and changes in visceral fat and glucose metabolism before the onset of type 2 diabetes. |
| Q60908626 | Clinical phenotyping of newly diagnosed type 2 diabetes in Yemen |
| Q92178332 | Clusters of Glycemic Response to Oral Glucose Tolerance Tests Explain Multivariate Metabolic and Anthropometric Outcomes of Bariatric Surgery in Obese Patients |
| Q38615808 | Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment |
| Q47666804 | Diet-induced obesity leads to metabolic dysregulation in offspring via endoplasmic reticulum stress in a sex-specific manner. |
| Q35964956 | Dietary Fatty Acids Differentially Associate with Fasting Versus 2-Hour Glucose Homeostasis: Implications for The Management of Subtypes of Prediabetes |
| Q57160228 | Dietary Interventions for the Prevention of Type 2 Diabetes in High-Risk Groups: Current State of Evidence and Future Research Needs |
| Q40517664 | Differentiation of obese patients at moderate or higher Findrisc score based on their atherogenic index. |
| Q30276925 | Exercise resistance across the prediabetes phenotypes: Impact on insulin sensitivity and substrate metabolism |
| Q49608463 | Genetic aetiology of glycaemic traits: approaches and insights |
| Q92800581 | Heart Rate, Autonomic Function, and Future Changes in Glucose Metabolism in Individuals Without Diabetes: The Whitehall II Cohort Study |
| Q89827214 | Heritability of Curve Patterns in Oral Glucose Tolerance Test |
| Q39325486 | Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk |
| Q38307071 | High normal post-load plasma glucose, cardiometabolic risk factors and signs of organ damage in obese children |
| Q57388692 | Identification of relevant biomarkers for type 2 diabetes |
| Q36659399 | Identification of type 2 diabetes subgroups through topological analysis of patient similarity |
| Q47219486 | Is it possible to develop a 'one-size fits all' prediction model for undiagnosed Type 2 diabetes? |
| Q30389834 | Markers of cardiovascular risk, insulin resistance, and ventricular dysfunction and remodeling in obese adolescents. |
| Q35093473 | Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study |
| Q38835951 | Phenotypes of prediabetes and stratification of cardiometabolic risk |
| Q40570455 | Physical activity energy expenditure vs cardiorespiratory fitness level in impaired glucose metabolism |
| Q35532317 | Sixty-five common genetic variants and prediction of type 2 diabetes |
| Q54422983 | The DEXLIFE study methods: identifying novel candidate biomarkers that predict progression to type 2 diabetes in high risk individuals. |
| Q38268577 | The Early Diabetes Intervention Program--is early actually late? |
| Q90724323 | The contribution of unrecognized factors to the diabetes epidemic |
| Q40443814 | The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program. |
| Q60921756 | Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss |
| Q45419245 | Towards a personalised diagnosis of type 2 diabetes |
| Q33843643 | Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study. |
| Q33920095 | Trajectories of metabolic risk factors and biochemical markers prior to the onset of type 2 diabetes: the population-based longitudinal Doetinchem study |
| Q35571816 | Trajectory of body mass index before the development of type 2 diabetes in Japanese men: Toranomon Hospital Health Management Center Study 15. |
| Q38622589 | Two Physical Activity Measures: Paffenbarger Physical Activity Questionnaire Versus Aerobics Center Longitudinal Study as Predictors of Adult-Onset Type 2 Diabetes in a Follow-Up Study |
| Q55100073 | Type 2 Diabetes: When Does It Start? |
Search more.